RP-6306 (Lunresertib) is the first-in-class, highly potent and selective PKMYT1 inhibitor that preferentially kills tumor cells overexpressing CCNE1 and was shown to inhibit the growth of a broad range of CCNE1-amplified tumors in xenograft/PDX preclinical models, both as a single agent and in combination therapy settings.
Molecular Weight:
324.38
Purity:
>99.0%
CAS Number:
[2719793-90-3]
Formula:
C18H20N4O2
Target:
Wee1
* VAT and and shipping costs not included. Errors and price changes excepted
